Is there any interaction between benzathine penicillin G and lidocaine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clinically Significant Drug Interaction Between Benzathine Penicillin G and Lidocaine

There is no clinically significant drug interaction between benzathine penicillin G and lidocaine—in fact, mixing lidocaine with benzathine penicillin G is an evidence-based practice specifically recommended to reduce injection pain without compromising antibiotic efficacy.

Evidence-Based Practice for Pain Reduction

The most recent and highest quality evidence demonstrates that adding lidocaine as a diluent to benzathine penicillin G significantly reduces injection pain without affecting penicillin pharmacokinetics or therapeutic effectiveness 1. This practice is explicitly recommended in current international consensus guidelines for patients requiring long-term secondary antibiotic prophylaxis, particularly in rheumatic fever prevention 1.

Key Clinical Evidence:

  • Immediate pain reduction: Lidocaine mixed with benzathine penicillin G reduces immediate post-injection pain by approximately 3.84 points on a 10-point scale (moderate quality evidence) 2
  • Sustained benefit: Pain reduction persists at 5 minutes (mean difference -2.85) and 20 minutes (mean difference -1.85) post-injection 2
  • No pharmacokinetic interference: Peak serum penicillin concentrations remain identical whether diluted with sterile water (0.100 μg/ml) or lidocaine 1% (0.102 μg/ml) 3
  • Improved adherence: Pain reduction strategies, including lidocaine addition, improve long-term adherence to prophylactic regimens—critical for preventing rheumatic heart disease progression 1

Recommended Administration Protocol

For benzathine penicillin G injections, add 0.2-0.4 mg/kg of 1% lidocaine (or 0.5 ml for adults) directly to the benzathine penicillin G solution before intramuscular injection 1, 4, 5. This should be standard practice, not an optional consideration.

Practical Implementation:

  • Use preservative-free lidocaine when possible to minimize additional allergic risk
  • Mix thoroughly before administration
  • Apply standard intramuscular injection technique (Z-track method may provide additional benefit) 6
  • Monitor for 30 minutes post-injection as with any penicillin administration

Safety Considerations

The FDA drug labels for both medications list no contraindications to concurrent use 7, 8. While both drugs can cause allergic reactions independently, there is no evidence of synergistic toxicity or enhanced adverse effects when combined 3, 4, 5, 2.

Important Caveats:

  • Lidocaine allergy: If the patient has a documented lidocaine allergy, alternative local anesthetics (mepivacaine or procaine) can be used with similar pain-reducing benefits 2
  • Penicillin allergy remains the primary concern: The addition of lidocaine does not change penicillin allergy risk or management 7
  • Hoigne's syndrome: This rare CNS reaction to benzathine penicillin G (confusion, hallucinations, fear of death) is not increased by lidocaine addition and is more commonly associated with procaine penicillin formulations 7

Monitoring Requirements:

Standard post-injection observation (30 minutes) applies regardless of lidocaine addition. Watch for:

  • Immediate hypersensitivity reactions (primarily penicillin-related)
  • Vasovagal responses
  • Local injection site reactions

The evidence consistently demonstrates that lidocaine addition is a safe, effective intervention that should be standard practice rather than an optional consideration, particularly for patients requiring repeated injections for rheumatic fever prophylaxis or syphilis treatment 1, 4, 5, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.